TABLE 3

Summary of survival for lung transplant recipients in the post-LAS period for NCFB compared to an age- and sex-matched cohort

GroupMedian (IQR) years1-year survival %5-year survival %10-year survival %
NCFB6.0 (2.3–11.9)875316
Matched cohort5.5 (2.3–13.2)845528

LAS: lung allocation score; NCFB: non-cystic fibrosis bronchiectasis; IQR: interquartile range.